Small Molecules

06 Feb 2007 Arena Pharmaceuticals Completes Enrollment with 3,182 Patients in Lorcaserin Phase 3 BLOOM Trial for Obesity
06 Feb 2007 elbion and Wyeth Enter Collaboration to Develop New Treatments for Schizophrenia
06 Feb 2007 Antipodean Pharmaceuticals Initiates Phase 2 Trial in Hepatitis
06 Feb 2007 Cyclacel announces development plan for its seliciclib CDK inhibitor to treat nasopharyngeal cancer
05 Feb 2007 Phase III Trial of Progesterone for the Prevention of Preterm Birth in Women
03 Feb 2007 GlaxoSmithKline receives approvable letter for new indications for Arixtra(R) (fondaparinux sodium) injection
03 Feb 2007 Schering-Plough Cites Today's Anacor Agreement as Latest in Series of Deals
03 Feb 2007 Biodelivery Sciences Announces FDA Acceptance of Bioral Amphotericin IND
03 Feb 2007 Hollis-Eden Pharmaceuticals Presents Positive Data with HE3286 in Preclinical Model of Established Rheumatoid Arthritis
03 Feb 2007 FDA Approves New Dosing Recommendations for RAPAMUNE in High Immunologic Risk Renal Transplant Patients
03 Feb 2007 GTx's Phase III Clinical Development of ACAPODENE on Course Following Planned Safety Review
03 Feb 2007 Positive Results of Phase 4 Clinical Study Evaluating Effects of Oracea(TM) (doxycycline, USP) Capsules, 40 mg, in Combination with MetroGel® (metronidazole gel), 1%, as Treatment for Rosacea Presented at Annual Meeting of the AAD
02 Feb 2007 Metabasis Announces Completion of Enrollment in the Phase 2b Clinical Trial for CS-917 in Patients With Type 2 Diabetes
02 Feb 2007 Neurochem announcement regarding the completion of its North American Phase III clinical trial for tramiprosate (ALZHEMEDâ„¢) for the treatment of Alzheimer's disease
02 Feb 2007 Preliminary clinical data for mecamylamine (AGI-004) and arbaclofen (AGI-006)
01 Feb 2007 AstraZeneca and Palatin Technologies Announce Worldwide Collaboration to Discover, Develop and Commercialise Obesity Compounds
01 Feb 2007 Lab International Initiates Patient Enrollment In The Extension Of Its Phase IIB Fentanyl Taifun(R) Trial
01 Feb 2007 Curis, Inc. Announces Dosing of First Patient in Hedgehog Antagonist Phase I Clinical Trial
01 Feb 2007 Pharmion Announces FDA Acceptance of IND for Oral Azacitidine
01 Feb 2007 Theratechnologies launches confirmatory Phase 3 trial testing TH9507
01 Feb 2007 NeuroDerm's Transdermal L-DOPA Parkinson’s Patch Completes First Clinical Trial
01 Feb 2007 Polydex Pharmaceuticals Drug Trial Halted After HIV Risk Seen
01 Feb 2007 Athenagen’s Eye Drop Therapy for AMD is Safe and Well Tolerated in Phase I Study
01 Feb 2007 Gemin X Initiates Phase 1/2 Combination Trials with GX15-070 in Non-Small Cell Lung Cancer and Mantle Cell Lymphoma
01 Feb 2007 Nexmed Announces Patient Dosing In Phase 3 Program For Anti-Fungal Product

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up